Posts by author
Alberto Costa
Henry Rodriguez: driving the next step in precision medicine and international Cancer Moonshot cooperation
Precision cancer medicine aims to improve diagnosis and treatment at the molecular level. Although genomics has influenced what precision medicine encompasses today, research is at a turning point. There is currently a common public (and often governmental) misconception that data…
Manfred Weber – chair of the European Parliament EPP group
Alberto Costa: How was Europe’s Beating Cancer Plan conceived and designed? Manfred Weber: The European Union is ultimately there to make the lives of Europeans better. For European politicians, this is our end goal. We know that with less than…
Association of steroid use with survival in solid tumours
Interview with Fausto Petrelli, oncology unit, asst Bergamo ovest, Treviglio (Italy). Q.Steroids are commonly used in patients with solid tumours for supportive therapy. Your systematic review and metanalysis recently published in European Journal of Cancer seems to question the real…
Bridging the Age Gap in Breast Cancer: A treatment selection tool for the over-70s
Q. Surgery tends to be a bigger issue for older people, and physicians need reliable guidance on who is likely to benefit and who could be harmed. You looked at selection practices and outcomes at 56 breast units across the…
World Cancer Day: we commemorate Professor Agim Sallaku
Since 2008, rallies around World Cancer Day on the 4th of February, support collective actions for a healthier world without cancer. The current Covid19 pandemic which placed the medical staff in the front line of leading the battle against the…
Liquid biopsy for early stage lung cancer moves closer
Interview with Christian Rolfo, MD, PhD, MBA, Dr.h.c. director of the Thoracic Medical Oncology and the Early Clinical Trials and Experimental Therapeutics Research Program investigator at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. Q. Your article…
The cost of cancer in Europe
Interview with Thomas Hofmarcher, health economist, IHE - The Swedish Institute for Health Economics, Lund, Sweden. Q. Which is the origin of your idea of studying the cost of cancer in Europe? Does the Swedish Institute for Health Economics have a…
Cervical cancer: the SENTIX trial
Interview with David Cibula, MD, Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Q. Your recent paper in the European Journal of Cancer (EJC 137 (2020) 69-80) on the SENTIX…
Stella Kyriakides: EU Commissioner for Health
When Stella Kyriakides took on the post of EU Health Commissioner in September 2019, Europe’s cancer community knew they could trust her to fight their cause. Within months she was launching a public consultation on Europe’s Beating Cancer Plan. Then…
Dose dense chemotherapy in Luminal B breast cancers
Interview with Lucia Del Mastro, MD, Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Italy. Q. Your recent paper in the European Journal of Cancer (EJC 136 (2020) 43-51) on the GIM2 trial is clearly…